¹«ºÀÇÕ À¯¸®Ã¼ ÀýÁ¦¼ú ±ÇÀ§ÀÚ
¾È°ú ¸Á¸·ºÐ¾ßÀÇ ¼±µÎÁÖÀÚ·Î ÁÖ¿ä Áø·á ºÐ¾ß´Â ¸Á¸·, À¯¸®Ã¼, Æ÷µµ¸·, Ȳ¹Ýº¯¼ºÀÌ´Ù. ±¹³» ÃÖÃÊ·Î 23°ÔÀÌÁö ¹«ºÀÇÕ À¯¸®Ã¼ ÀýÁ¦¼úÀ» µµÀÔÇØ ¼ö¼ú ÈÄ È¯ÀÚÀÇ ºÒÆí°ú ÇÕº´ÁõÀ» °¨¼Ò½Ã۰í, ¼ö¼ú ½Ã°£ ¹× ¼ö¼ú ÈÄ »çȸ»ýȰ º¹±Í ½Ã°£À» ´ÜÃà½ÃÄ×´Ù. À¯¸®Ã¼ ÀýÁ¦¼úÀº ¸Á¸·¹Ú¸®¿Í °°Àº Áúȯ¿¡¼ ¸Á¸·À» ÀçÀ¯Âø ½ÃŰ´Â µî Áúº´À» À¯¹ßÇÏ´Â ÀÌ»óÁ¶Á÷À» Á¦°ÅÇÏ´Â ¹æ¹ýÀε¥, ¹«ºÀÇÕ À¯¸®Ã¼ ÀýÁ¦¼úÀº ´çÀÏ ¼ö¼úÀÌ °¡´ÉÇϰí ÅëÁõÀÌ ÀûÀ¸¸é¼µµ ½Ã·Âȸº¹ÀÌ »¡¶ó ȯÀڵ鿡°Ô Å« È£ÀÀÀ» ¾ò°í ÀÖ´Ù.
Á¦ ¸ñ | Pathogenic Risk Factors and Associated Outcomes in the Bullous Variant of Central Serous Chorioretinopathy. Ophthalmol | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.04 | ¹ßÇ¥Áö | Ophthalmol Retina. |
Á¦ ¸ñ | Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration: 24-month outcomes. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.03 | ¹ßÇ¥Áö | Graefes Arch Clin Exp Ophthalmol. |
Á¦ ¸ñ | Efficacy and safety of primary posterior capsulotomy during phaco-vitrectomy for epiretinal membrane. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.01 | ¹ßÇ¥Áö | BMC Ophthalmol. |
Á¦ ¸ñ | Peripapillary Microvasculature of the Retina and Choriocapillaris in Uninvolved Fellow Eyes of Unilateral Retinal Vein Occlusion Patients. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.01 | ¹ßÇ¥Áö | Retina. |
Á¦ ¸ñ | AICAR upregulates ABCA1/ABCG1 expression in the retinal pigment epithelium and reduces Bruch's membrane lipid deposit in ApoE deficient mice. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021.12 | ¹ßÇ¥Áö | Exp Eye Res. |
Á¦ ¸ñ | Epiretinal membrane surgery in patients with multifocal versus monofocal intraocular lenses. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021.12 | ¹ßÇ¥Áö | Retina |
Á¦ ¸ñ | Temporal changes of parafoveal microvasculature after epiretinal membrane surgery: an optical coherence tomography angiography study. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021.09 | ¹ßÇ¥Áö | Retina. |
¼¿ï´ëº´¿øÀº º»¿øÀ» ºñ·ÔÇÑ ¾î¸°À̺´¿ø, ¾Ïº´¿ø, ÀÇ»ý¸í¿¬±¸¿øÀ¸·Î ±¸¼ºµÅ ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î 1786º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. 540¿© ¸íÀÇ ±³¼ö¿Í 5400¿© ¸íÀÇ Á÷¿øÀÌ ÇÏ·ç Æò±Õ 1700¿© ¸íÀÇ ÀÔ¿øÈ¯ÀÚ¿Í 8600¸íÀÌ ³Ñ´Â ¿Ü·¡È¯ÀÚ¸¦ µ¹º¸°í ÀÖ´Ù. ¼¼°èÀû ÷´Ü Áø·á ¿µ¿ªÀ» Áö¼ÓÀûÀ¸·Î È®º¸ÇÔÀ¸·Î½á ÃÖ»óÀÇ Áø·á ¼ºñ½º¸¦ Á¦°øÇϰí, ¿ì¸®³ª¶ó ÀÇ·á ¼±ÁøÈ¸¦ Ãß±¸ÇÏ´Â Á¤Ã¥ Çù·Â º´¿øÀÌ´Ù.
¼¿ïƯº°½Ã Á¾·Î±¸ ´ëÇзΠ101